Home » Science & Technology » Circulating Tumor Cells in BrCa: Understanding a Validated Diagnostic Tool for Precision Medicine

Circulating Tumor Cells in BrCa: Understanding a Validated Diagnostic Tool for Precision Medicine

Written By Menarini Silicon Biosystems on Thursday, Apr 01, 2021 | 05:14 AM

 
This webinar will provide an overview of the current state of circulating tumor cell (CTC) enumeration for clinical use in metastatic breast cancer. Dr. Massimo Cristofanilli, Associate Director of Translational Research and Precision Medicine at Robert Lurie Cancer Center, Northwestern University, will review the evidence, as well as clinical case studies demonstrating how CTCs can be utilized in clinical practice and clinical research studies in metastatic breast cancer.